PLIN2 and early-onset autosomal dominant Alzheimer disease: The aims of this study were to (i) identify ADRP in a cohort of CSF biomarker-positive AD patients; (ii) to correlate the newly identified ADRP expression with patients’ clinical measures; (iii) to validate it on independent cohorts of patients with AD, behavioral variant of frontotemporal dementia (bvFTD) and on two mild cognitive impairment (MCI) cohorts, one due to Alzheimer’s disease and one due to other causes.